Advisors

Since 2015, Dr. Cavenee is Director, Strategic Alliances-CNS of Ludwig Cancer Research with global responsibilities. He is also Distinguished Professor of Medicine at the University of California, San Diego.

Dr. Croce entered the school of medicine of La Sapienza University of Rome and graduated in 1969 summa cum laude…

Pamela Garzone, Ph.D., joined Calibr as Chief Medical Officer in May 2019, bringing decades of clinical research experience, spanning large pharmaceutical companies, biotech startups and academia...

Since 2001 Dr. Kucherlapati is the Paul C. Cabot Professor of Genetics and Professor of Medicine at Harvard Medical School and was the first...

Amy Millman is a passionate advocate for women entrepreneurs building Big Businesses Starting Small. In 2000, Amy co-founded Springboard Enterprises ...

Dr. Wenseng “Wendy” Pan, partner in Goodwin’s Technology & Life Sciences group, focuses on mergers and acquisitions, technology-based transactions, strategic partnerships and financing transactions...

A medicinal chemistry scientist turned patent attorney, Dr. Eifion Phillips has helped secure his clients’ intellectual property portfolios across various fields and innovations...

Dr. Sabapathy obtained his Ph.D. in Molecular and Cellular Immunology from the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore, in 1995.

Paul Schimmel, Ph.D., is a biophysical chemist and he received his B.A. in biochemistry and biophysics from Ohio Wesleyan University in 1962...

Dr. Peter Vogt is a molecular biologist, virologist and geneticist. His research focuses on retroviruses and viral and cellular oncogenes.

Daniel D. Von Hoff, M.D., F.A.C.P. FASCO, FAACR is currently Physician in Chief, Distinguished Professor at the Translational Genomics Research Institute (TGen) in Phoenix, Arizona.